ID   TBCN-1
AC   CVCL_0T71
DR   Wikidata; Q54971751
RX   PubMed=9824643;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 54 hours (PubMed=9824643).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=9824643; DOI=10.3892/ijo.13.6.1269;
RA   Koike, Naoto
RA   Todoroki, Takeshi
RA   Kawamoto, Toru
RA   Yoshida, Sadao
RA   Kashiwagi, Hironobu
RA   Fukao, Katashi
RA   Ohno, Tadao
RA   Watanabe, Teruo
RT   "The invasion potentials of human biliary tract carcinoma cell lines:
RT   correlation between invasiveness and morphologic characteristics.";
RL   Int. J. Oncol. 13:1269-1274(1998).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan, Abdulkadir
RA   Yenigun, Ali
RA   Soma, Daiki
RA   Aksu, Eric
RA   Lopez, Kevin
RA   Park, Yujin
RA   Cross-Najafi, Arthur
RA   Li, Ping
RA   Kundu, Debjyoti
RA   House, Michael G.
RA   Chakraborty, Sanjukta
RA   Glaser, Shannon
RA   Kennedy, Lindsey
RA   Francis, Heather
RA   Zhang, Wen-Jun
RA   Alpini, Gianfranco D.
RA   Ekser, Burcin
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//